Common breast cancer susceptibility loci are associated with triple-negative breast cancer

Cancer Research

Volumn 71, Issue 19, 2011, Pages 6240-6249

  Stevens, Kristen N ^a   Vachon, Celine M ^a   Lee, Adam M ^a   Slager, Susan ^a   Lesnick, Timothy ^a   Olswold, Curtis ^a   Fasching, Peter A ^b   Miron, Penelope ^c   Eccles, Diana ^d   Carpenter, Jane E ^e   Godwin, Andrew K ^f   Ambrosone, Christine ^g   Winqvist, Robert ^g   Brauch, Hiltrud ^{i,p,x,ak,al,am}   Schmidt, Marjanka K ^j   Cox, Angela ^k   Cross, Simon S ^k   Sawyer, Elinor ^l   Hartmann, Arndt ^o   Beckmann, Matthias W ^o   Schulz Wendtland, Rud̈iger ^o   Ekici, Arif B ^o   Tapper, William J ^d   Gerty, Susan M ^d   Durcan, Lorraine ^d   Graham, Nikki ^d   Hein, Rebecca ^p   Nickels, Stephan ^p   Flesch Janys, Dieter ^r   Heinz, Judith ^r   Sinn, Hans Peter ^q   Konstantopoulou, Irene ^s   Fostira, Florentia ^s   Pectasides, Dimitrios ^s   Dimopoulos, Athanasios M ^s   Fountzilas, George ^t   Clarke, Christine L ^e   Balleine, Rosemary ^u   Olson, Janet E ^a   Fredericksen, Zachary ^a   Diasio, Robert B ^a   Pathak, Harsh ^v   Ross, Eric ^v   Weaver, JoEllen ^v   Rüdiger, Thomas ^w   Försti, Asta ^p,an   Dünnebier, Thomas ^p   Ademuyiwa, Foluso ^g   Kulkarni, Swati ^g   Pylkäs, Katri ^h   Jukkola Vuorinen, Arja ^h   Ko, Yon Dschun ^x   Van Limbergen, Erik ^y   Janssen, Hilde ^y   Peto, Julian ^m   Fletcher, Olivia ⁿ   Giles, Graham G ^ab   Baglietto, Laura ^ab   Verhoef, Senno ^j   Tomlinson, Ian ^ac   Kosma, Veli Matti ^ad   Beesley, Jonathan ^ae   Greco, Dario ^af   Blomqvist, Carl ^af   Irwanto, Astrid ^ag   Liu, Jianjun ^ag   Blows, Fiona M ^ah   Dawson, Sarah Jane ^ah   Margolin, Sara ^aj   Mannermaa, Arto ^ad   Martin, Nicholas G ^ae   Montgomery, Grant W ^ae   Lambrechts, Diether ^z,aa   Dos Santos Silva, Isabel ^m   Severi, Gianluca ^ab   Hamann, Ute ^p,an   Pharoah, Paul ^ah   Easton, Douglas F ^ai   Chang Claude, Jenny ^o   Yannoukakos, Drakoulis ^q   Nevanlinna, Heli ^af   Wang, Xianshu ^a   Couch, Fergus J ^a   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^g ROSWELL PARK CANCER INSTITUTE   (United States)

^h UNIVERSITY OF OULU   (Finland)

ⁱ DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^j NETHERLANDS CANCER INSTITUTE   (Netherlands)

^k UNIVERSITY OF SHEFFIELD   (United Kingdom)

^l GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^m LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

ⁿ INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^o UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^p GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^q UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^r UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^s UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^t ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^u WESTMEAD HOSPITAL   (Australia)

^v FOX CHASE CANCER CENTER   (United States)

^w STÄDTISCHES KLINIKUM KARLSRUHE   (Germany)

^x Johanniter Krankenhaus   (Germany)

^y UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^z DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^aa UNIVERSITY OF LEUVEN   (Belgium)

^ab UNIVERSITY OF MELBOURNE   (Australia)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY OF EASTERN FINLAND   (Finland)

^ae QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^af HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^ag GENOME INSTITUTE OF SINGAPORE   (Singapore)

^ah UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ai UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^aj KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^ak UNIVERSITY OF TÜBINGEN   (Germany)

^al UNIVERSITY OF BONN   (Germany)

^am INSTITUT DER RUHR UNIVERSITÄT BOCHUM IPA   (Germany)

^an LUND UNIVERSITY   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME PROTEIN; PROTEIN ESR1; PROTEIN RAD51L1; PROTEIN TOX3; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CAUCASIAN; CHROMOSOME 19P; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN VARIANT; SINGLE NUCLEOTIDE POLYMORPHISM; TRIPLE NEGATIVE BREAST CANCER;

EID: 80053375835     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1266     Document Type: Article

References (40)

1. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med 2010;363:1938-48.
2. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 2007;16:439-43. (Pubitemid 46548646)
3. Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, et al. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res 2008;14:8010-8.
4. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG, et al. Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 2008;109:123-39. (Pubitemid 351538762)
5. Bauer KR, Brown M, Cress RD, Parise CA, Caggiano V. Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population-based study from the California cancer Registry. Cancer 2007;109:1721-8.
6. Irvin WJ Jr, Carey LA. What is triple-negative breast cancer? Eur J Cancer 2008;44:2799-805.
7. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007;447:1087-93.
8. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007;39:870-4.
9. Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, Gudjonsson SA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2007;39:865-9.
10. Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 2008;40:703-6.
11. Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet 2009;41:585-90.
12. Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet 2009;41:579-84.
13. Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genomewide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet 2009;41:324-8.
14. Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al. Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet 2010;42:504-7.
15. Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptornegative breast cancer in the general population. Nat Genet 2010; 42:885-92.
16. Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al. Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study. J Natl Cancer Inst 2011;103:425-35.
17. Garcia-Closas M, Chanock S. Genetic susceptibility loci for breast cancer by estrogen receptor status. Clin Cancer Res 2008;14:8000-9.
18. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, Richesson DA, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 2008;4:e1000054.
19. Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet 2011;20:3289-303.
20. Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 2008;82:937-48.
21. Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 2010;70:9742-54.
22. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA, et al. A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 2007;39:352-8. (Pubitemid 46328496)
23. Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, Benitez J, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the Breast Cancer Association Consortium: a combined case-control study. Breast Cancer Res 2010; 12:R110.
24. Li J, Humphreys K, Darabi H, Rosin G, Hannelius U, Heikkinen T, et al. A genome-wide association scan on estrogen receptor-negative breast cancer. Breast Cancer Res 2010;12:R93.
25. Leu M, Humphreys K, Surakka I, Rehnberg E, Muilu J, Rosenstrom P, et al. NordicDB: a Nordic pool and portal for genome-wide control data. Eur J Hum Genet 2010;18:1322-6.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
28. Stacey SN, Sulem P, Zanon C, Gudjonsson SA, Thorleifsson G, Helgason A, et al. Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet 2010;6: e1001029.
29. Asselin-Labat ML, Vaillant F, Sheridan JM, Pal B, Wu D, Simpson ER, et al. Control of mammary stem cell function by steroid hormone signalling. Nature 2010;465:798-802.
30. Joshi PA, Jackson HW, Beristain AG, Di Grappa MA, Mote PA, Clarke CL, et al. Progesterone induces adult mammary stem cell expansion. Nature 2010;465:803-7.
31. Tapper W, Hammond V, Gerty S, Ennis S, Simmonds P, Collins A, et al. The influence of genetic variation in 30 selected genes on the clinical characteristics of early onset breast cancer. Breast Cancer Res 2008;10:R108.
32. Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet 2010;42:880-4.
33. Feng L, Huang J, Chen J. MERIT40 facilitates BRCA1 localization and DNA damage repair. Genes Dev 2009;23:719-28.
34. Shao G, Patterson-Fortin J, Messick TE, Feng D, Shanbhag N, Wang Y, et al. MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks. Genes Dev 2009;23:740-54.
35. Wang B, Hurov K, Hofmann K, Elledge SJ. NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control. Genes Dev 2009;23:729-39.
36. Lio YC, Mazin AV, Kowalczykowski SC, Chen DJ. Complex formation by the human Rad51B and Rad51C DNA repair proteins and their activities in vitro. J Biol Chem 2003;278:2469-78. (Pubitemid 36801323)
37. O'Flaherty E, Kaye J. TOX defines a conserved subfamily of HMG-box proteins. BMC Genomics 2003;4:13.
38. Gown AM. Current issues in ER and HER2 testing by IHC in breast cancer. Mod Pathol 2008;21 Suppl 2:S8-15.
39. Allred DC, Carlson RW, Berry DA, Burstein HJ, Edge SB, Goldstein LJ, et al. NCCN Task Force Report: estrogen receptor and progesterone receptor testing in breast cancer by immunohistochemistry. J Natl Compr Canc Netw 2009;7 Suppl 6:S1-21; quiz S2-3.
40. Ambrosone CB, Nesline MK, Davis W. Establishing a cancer center data bank and biorepository for multidisciplinary research. Cancer Epidemiol Biomarkers Prev 2006;15:1575-7. (Pubitemid 44497088)